Geoffrey Levin concentrates his practice on complex business transactions and governance matters. His representations span a variety of industries, situations and enterprise values, having counseled clients on domestic and international mergers, acquisitions, leveraged buyouts, going private transactions, proxy contests, spin-offs, joint ventures, recapitalizations, venture capital financing, growth equity investments, senior and junior debt financings, restructurings and workouts. He also has extensive experience advising private equity sponsors and their portfolio companies.
Geoff's representations have covered a broad range of industries including life sciences, financial services, communications, energy, retail, automotive and heavy industrial.
Prior to joining Cadwalader, Geoffrey was a partner at Kirkland & Ellis and an associate at Cravath, Swaine & Moore. He authored the article Private Equity Club: Seller Beware? Latest Developments and Practice Tips, which appeared in the March-April 2007 edition of Deal Lawyers.
Geoffrey was recently named by IFLR 1000 as a leading M&A lawyer. He was also recognized by Institutional Investor News as one of the 10 Rising Stars of Private Equity and M&A Law, and by Mergermarkets as one of their 2009 Dealmakers of the Year.
Geoffrey received his J.D., magna cum laude and Order of the Coif, from the University of Minnesota, where he was executive editor of the Journal of International Economic Law & Policy, and a B.B.A., with high distinction, from the University of Michigan. He is admitted to practice in the State of New York.
Mergers & Acquisitions and Restructurings
•Salix Pharmaceuticals on its terminated combination with Cosmo Technologies Ltd.
•The Management Team of Medpace in its $900 million acquisition by Cinven.
•Vertis Holdings in its $363 million sale to Quad/Graphics.
•A privately owned medical device company in its sale to a strategic acquirer.
•Icahn Capital in its bid for Blockbuster, Inc.
•ZS Fund in the acquisition of SOS Security.
•A biomass conversion start-up in equity financing.
•A consortium of family office investors in bid for the Lafarge Gypsum business.
•A consortium of hedge funds in a bid for over $6 billion in distressed real estate assets.
•CVC Capital Partners in its $4.4 billion agreement to acquire the iShares ETF business from Barclays.
•The U.S. Treasury in the Chrysler restructuring.
•CVC Capital Partners in its $2.3 billion take private acquisition of Univar N.V.
•Lyondell Chemical Company in the equity backstop by Apollo, Ares and Access Industries of a $2.8 billion rights offering.
•A private equity fund in its bid for the eTrade Market Making business.
Joint-Ventures/Growth Equity/Venture Capital Investments
•A leading private equity firm with an exclusive focus on life sciences industries in multiple investments in domestic and multinational medical technology companies.
•A private investment fund in a $30 million PIPE financing of biopharmaceutical company.
•A private investment fund in a $75 million PIPE financing of National City Corporation.
•A management team in seed-capital funding arrangements for start-up.
•An investment fund in a $100 million funding commitment and joint venture arrangements for start-up.
•Columbus Nova in a multi-tranche funding of a public company.
•CVC Capital Partners in raising over $20 billion of committed capital for their European and Asian Investment Funds.
•The general partners and limited partners in the formation of a wide variety of other country- or region-specific non-U.S. funds as well as sector funds.